Global Pharma Companies Seek EU Support Amid US Tariff Threats

Pharmaceutical Industry Concerns in the EU

• 🌍 Nearly three dozen global pharmaceutical companies have formally requested assistance from the EU to sustain their operations.
• ⚠️ This plea comes ahead of anticipated US tariffs on imported goods, which threaten to create cost disadvantages.

Key Demands to the European Commission

• 💰 Companies are seeking measures to offset the costs associated with pharmaceutical innovations.
• 📜 A simplification of regulatory processes, including multi-country clinical trials, is also a key demand.
• 📉 Concerns were raised that US tariffs could accelerate the industry's migration towards the United States, away from Europe.

Interconnected Supply Chains and Market Dynamics

• 📈 The US represents the largest market by sales for major pharmaceutical firms.
• 🤝 Europe and the US share interconnected supply chains for medicines.
• 📊 In 2023, EU medical and pharmaceutical exports to the US amounted to over $11 billion.